Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Karim Budhwani, PhD, DLA
CEO-SCIENTIST, CERFLUX, INC.
Is Your Billion-Dollar Oncology AI Cutting-Edge Technology or is it Artificial Ignorance?
Julie Bullock
SENIOR VICE PRESIDENT, CERTARA
Dose Optimization in Oncology: How Do We Tackle the Tricky Topic of Combinations?
Matthew Burkhardt
DIRECTOR, B LABS
Comparative Views on Wet Lab Incubation
Philadelphia, Pennsylvania, United States
Christopher Burns
PRESIDENT AND CEO, VENATORX PHARMACEUTICALS, INC.
Tackling the Global Challenge of Antimicrobial Resistance: What Will It Take?
Malvern, Pennsylvania, United States
Placeholder Photo
Pamela Bush, Ph.D., MBA
CHIEF BUSINESS OFFICER, PREDICTIVE ONCOLOGY
Predictive Oncology
Stuart Cable
VICE CHAIRMAN, GLOBAL CHAIR OF M&A, GOODWIN
Fireside Chat with Noubar Afeyan, CEO, Flagship Pioneering
Robert Califf, MD, MACC
FDA COMMISSIONER, U.S. FOOD AND DRUG ADMINISTRATION
A Conversation with Robert M. Califf, MD
Riccardo Canevari
CEO, RADIOPHARM THERANOSTICS
Radiopharm Theranostics
Livingston, New Jersey, United States
Ping Cao, ACA
CHIEF BUSINESS OFFICER, HENLIUS BIOTECH
Henlius Biotech
Milpitas, California, United States
Dawn Cardeiro, M.S.
DIRECTOR OF PRECISION MEDICINE, POINT32HEALTH
Prescient Diagnostics: Implications for Product Development and Reimbursement